Bookmark
Forward
Toxoplasmosis and treatment for rheumatic diseases: what are the risks?
Barbara M Lund, David G I Scott
Rheumatology (Oxford, England) 2021 Jan 05
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Barbara M Lund, David G I Scott.
Toxoplasmosis and treatment for rheumatic diseases: what are the risks?
Rheumatology (Oxford, England).
2021 Jan 05;60(1):5-7
Mesh Tags
Animals
Antirheumatic Agents
Humans
Rheumatic Diseases
Toxoplasmosis
Substances
Antirheumatic Agents
PMID: 33211883
View Full Text